سعر Ringer acetate (Otsuka) i.v. infusion 500 ml 2026

Ringer's acetate solution for intravenous infusion, 500 ml, used for fluid and electrolyte replacement.

• Replacement of extracellular fluid and electrolyte loss or short-term volume replacement (alone or with colloid)Population: Adults and childrenSwedish Medical Products Agency (Lakemedelsverket) product document

• Hypersensitivity/anaphylactoid reactions and urticaria (frequency not known).International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document
• Hyponatremia, overhydration, electrolyte disturbances, hyponatremic encephalopathy (frequency not known).International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document
• Common: heart failure in patients with cardiac disorders, pulmonary edema, febrile reaction, injection site infection, pain, vein irritation, thrombosis or phlebitis, extravasation.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document

• Known hypersensitivity to the product or its ingredients.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document
• Extracellular hyperhydration or hypervolemia.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document
• Concomitant ceftriaxone in preterm and term newborns (28 days or younger), even with separate lines.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document

• Ceftriaxone must not be mixed or given simultaneously with calcium-containing IV solutions at any age.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document
• High-volume infusion needs specific monitoring in cardiac or pulmonary failure, edema, ascitic cirrhosis or renal insufficiency.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document
• Risk of acute hyponatremia and hyponatremic encephalopathy, especially in children and patients with non-osmotic vasopressin release; monitor fluid balance and electrolytes.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document

• CeftriaxoneContraindicated in neonates; never mixed or given simultaneously at any age.Swedish Medical Products Agency (Lakemedelsverket) product document
• Drugs lowering serum sodium (diuretics, NSAIDs, antipsychotics, SSRIs, opioids, antiepileptics, oxytocin, chemotherapy)Increased risk of hyponatremia.Swedish Medical Products Agency (Lakemedelsverket) product document
• SuxamethoniumWith potassium may cause considerable hyperkalemia.Swedish Medical Products Agency (Lakemedelsverket) product document

• Can be used during pregnancy; during labour, especially with oxytocin, there may be an increased risk of hyponatremia.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document
• Can be used during lactation.International label, equivalent formulation · Swedish Medical Products Agency (Lakemedelsverket) product document